中药联合TACE治疗原发性肝癌疗效的系统评价

摘要/Abstract

摘要： 目的系统评价中药联合TACE治疗原发性肝癌的疗效。方法计算机检索中文数据库和英文数据库自2010年至2020年5月收录的中药联合TACE治疗原发性肝癌的RCT文献,经Cochrane风险偏倚评估手册质量评估后纳入的文献,采用Review Manager 5.3软件进行meta分析。结果检索文献共1 222篇,筛选后纳入27篇,总样本量2 171例。meta分析得出:中药联合TACE治疗原发性肝癌患者近期疗效以化瘀为治疗原则的疗效最佳;中药联合TACE治疗原发性肝癌对比单纯TACE治疗,患者的半年生存期虽无明显差异,但1年生存期化瘀类中药联合TACE治疗优于单纯TACE治疗;2年生存期扶正、化瘀类中药联合TACE治疗优于单纯TACE治疗,且以化瘀类中药疗效为佳;中药联合TACE治疗原发性肝癌患者Karnofsky体力状况评分(KPS)明显优于单纯TACE治疗。结论中药联合TACE治疗原发性肝癌疗效优于单纯TACE治疗,尤其以化瘀类中药联合为著。

关键词: TACE, 中药, 中西医结合, 原发性肝癌, meta分析

Abstract: Objective To systematically evaluate the effectiveness of Combining theatment with Traditional Chinese Medicine (TCM) and Transcatheter Arterial Chemoembolization Therapy (TACE) for hepatocellular carcinoma (HCC), and to provide a reasonable supplementary scheme for the clinical management of HCC.Methods The literature of randomized controlled clinical studies on the treatment of HCC documented in Chinese and English databases from 2010 to March 2020 were searched online. The literature were screened by the quality evaluation of Cochrane handbook, and a meta-analysis was performed on the included studies with Review Manager 5.3 software.Results A total of 1222 references were retrieved, and 27 were included, with a total sample size of 2171 cases. By Meta-analysis it was shown that: 1.TCM combined with TACE was superior to simple TACE in terms of short-term therapeutic effect, and the therapeutic principle of removing blood stasis with traditional Chinese medicine is the best treatment; 2.Although there is no significant difference in the half year survival of patients with primary liver cancer treated by TCM in combination with TACE, the one-year survival rate of the treatment by removing blood stasis herbs in combination with TACE is better than that of TACE alone, and the two-year survival rate of Fuzheng and removing blood stasis herbs is better than that of TACE, and the curative effect of removing blood stasis herbs is the best; 3.TCM combined with TACE was superior to simple TACE in terms of KPS score, and the differences were statistically significant.Conclusion The efficacy of combining traditional Chinese medicine with TACE for HCC treatment is better than simple TACE, and the therapeutic effect of TCM for removing blood stasis is the best. More multi-center randomized controlled trials with larger sample sizes and high quality are still warranted to verify this result.

Key words: Transcatheter arterial chemoembolization, Traditional Chinese Medicine, Hepatocellular carcinoma, Meta analysis

何正阳, 商斌仪, 佘为民, 卓蕴慧. 中药联合TACE治疗原发性肝癌疗效的系统评价[J]. 肝脏, 2020, 25(12): 1262-1268.

HE Zheng-yang, SHANG Bin-yi, SHE Wei-ming, ZHUO Yun-hui. A meta-analysis on the clinical effect of combining Traditional Chinese Medicine and transcatheter arterial chemoembolization therapy for treating hepatocellular carcinoma[J]. Chinese Hepatolgy, 2020, 25(12): 1262-1268.

参考文献

[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin,2015,65:87-108.
[2] Shimada K, Sakamoto Y, Esaki M, et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol,2007,14:2337-2347.
[3] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 临床肝胆病杂志, 2011, 20:929-946.
[4] 于世英,胡国清. 肿瘤临床诊疗指南. 北京:科学出版社,2013.
[5] 中国抗癌协会肝癌专业委员会. 原发性肝癌诊断标准. 中华肝脏病杂志, 2000, 8:135.
[6] 郑筱萸. 中药新药临床研究指导原则(试行). 北京:中国医药科技出版社,2002.
[7] 秦凤展,陈振东,樊青霞,等.肿瘤内科治疗学.北京: 人民军医出版社,2004: 537-540.
[8] 徐森华,徐成兴,瞿春霞,等.加味柴芍六君子汤联合经肝动脉化疗栓塞治疗原发性肝癌临床观察.介入放射学杂志,2014,23:163-167.
[9] 乔喜婷, 王克穷, 代引海,等. 小柴胡汤联合肝动脉化疗栓塞术治疗原发性肝癌的临床观察. 陕西中医, 2014,35:835-836.
[10] 傅剑锋, 潘博, 蔡美. 肝喜片配合介入治疗原发性肝癌30例疗效观察. 湖南中医杂志, 2012:14-15.
[11] 储真真, 陈历宏, 黄祝晓,等. 复元活血汤联合介入治疗原发性肝癌的疗效分析. 国际中医中药杂志, 2014,36:426-429.
[12] 储真真, 林志杰, 陈历宏,等. 莲龙消积方联合榄香烯介入治疗中晚期原发性肝癌临床研究. 全国中医肿瘤学术年会暨岐黄论坛分论坛. 2015.
[13] 凌志琴. 中西医结合治疗肝癌. 吉林医学, 2010, 031:2284.
[14] 吴二光. 中西医结合治疗中晚期肝癌70例. 河南中医, 2014, 034:1081-1082.
[15] 商红叶. 原发性肝癌TACE术后联合自拟中药汤剂改善临床症状的临床观察. 世界中联肝病国际学术大会. 2013.
[16] 张信, 方文岩. 榄香烯联合TACE治疗原发性肝癌临床观察. 山西中医, 2015, 31:23-24.
[17] 张念华, 陈高峰, 史清华,等. 肝动脉栓塞化疗联合中药治疗原发性肝癌临床观察. 新中医, 2012, 44:72-75.
[18] 曾普华, 郜文辉, 蒋益兰,等. 益气化瘀解毒方加减联合化疗栓塞治疗中晚期原发性肝癌37例总结. 湖南中医杂志, 2011, 27:19-20.
[19] 朱守洋, 郜启权. 白花蛇舌草注射液在肝癌介入化疗近期疗效临床研究. 第三届国际中医、中西医结合肿瘤学术交流大会暨第十二届全国中西医结合肿瘤学术大会. 2010.
[20] 李京涛, 郭师, 席奇,等 . 益脾养肝方联合肝动脉化疗栓塞术治疗原发性肝癌的疗效观察. 陕西中医, 2015, 36:944-945.
[21] 李俊, 戚春厚. 肝动脉化疗栓塞术联合中药治疗中晚期肝癌的临床研究. 中国中西医结合影像学杂志, 2013,11:51-53.
[22] 杨泽江, 邓朝明, 刘俊波,等 . 中西医结合疗法对肝癌生活质量及免疫功能的影响. 中医学报, 2011,26:907-909.
[23] 栗广辉. 二黄扶正汤配合介入治疗原发性肝癌36例. 中医临床研究, 2013,16:89-90.
[24] 王国泰, 杨兴武, 王旗,等 . 黄芩苷胶囊联合肝动脉化疗栓塞术治疗原发性肝细胞癌疗效观察. 中西医结合肝病杂志, 2016,26:369-370.
[25] 田永贞,李红雨,杜洪涛.中西医结合治疗肝癌疗效研究.中医学报,2012,27:1246-1247.
[26] 石磊, 郝建梅, 李知强,等. 白莲化癖汤联合经肝动脉栓塞化疗术治疗原发性肝癌临床观察. 中西医结合肝病杂志, 2019,29:413-414.
[27] 苑静波, 苏春芝, 李光荣,等 . 扶正健脾中药对介入治疗后肝癌患者相关指标影响观察. 辽宁中医杂志, 38:2027-2028.
[28] 袁昌劲, 唐求, 孔庆志,等 . 中医辨证论治结合肝动脉介入治疗中晚期肝癌的临床观察. 湖北中医药大学学报, 2010, 12:50-51.
[29] 贾学平, 司银梅, 胡伟,等. 中药联合化疗栓塞术治疗原发性肝癌临床观察. 湖北中医杂志, 2013,35:9-10.
[30] 邓力, 黎壮伟, 吴薏婷,等. 复方苦参注射液持续静滴联合TACE治疗中晚期肝癌30例. 实用中医内科杂志, 2010,21:24-26.
[31] 陈德连, 江会红.榄香烯联合介入治疗中晚期肝癌患者的近期疗效. 广州中医药大学学报, 2016,33:27-30.
[32] 陶海云,万里新,魏光敏,等.艾迪注射液联合肝动脉化疗栓塞术治疗原发性肝癌临床研究.中医学报,2017,32:1157-1160.
[33] 顾本宇. 益气健脾疏肝中药联合化学药物动脉灌注治疗原发性肝癌32例. 中国中医药现代远程教育, 2011:68-69.
[34] 黄古叶, 罗耀昌, 龙富立,等 . 健肝颗粒联合经导管动脉栓塞术治疗原发性肝癌临床疗效研究. 中西医结合肝病杂志, 2013,23:259-261.
[35] 吴沛宏,张福君.肝癌微创治疗与多学科综合治疗.北京:军事医学科学出版社,2002:291-292.
[36] 崔岩.中医药在肝癌治疗中的应用体会.吉林中医药,2004,25:18-19.
[37] 史茜.原发性肝癌的中医药治疗研究.长春中医药大学学报,2008,19:399-400.